Stock Events

Stock Events

Milestone Pharmaceuticals 

$1.2200
67
-$0.02-1.61% Monday 05:03

Statistics

Day High
1.22
Day Low
1.2
52W High
2.04
52W Low
1.2
Volume
26
Avg. Volume
-
Mkt Cap
151.89M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17NovExpected
Q3 2025
Q1 2026
Q2 2026
Next
-0.22
-0.08
0.05
0.19
Expected EPS
-0.215714
Actual EPS
N/A

Financials

-4,078.78%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.55MRevenue
-63.06MNet Income

Analyst Ratings

$6.00Average Price Target
The highest estimate is 8.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MIST.BOATS. It's not an investment recommendation.
Palantir Technologies
15
PLTR
NVIDIA
12
NVDA
Microsoft
11
MSFT
Amazon
11
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap208.49B
Amgen develops cardiovascular drugs, competing in similar therapeutic areas as Milestone Pharmaceuticals.
Novartis
NVS
Mkt Cap266.8B
Novartis offers a broad range of heart and blood pressure medications, directly competing with Milestone's cardiovascular focus.
Pfizer
PFE
Mkt Cap157.65B
Pfizer has a diverse portfolio that includes treatments for cardiovascular diseases, making it a competitor.
Merck
MRK
Mkt Cap362.35B
Merck produces cardiovascular therapies, directly competing with Milestone Pharmaceuticals in the market.
Bristol-Myers Squibb
BMY
Mkt Cap128.81B
Bristol Myers Squibb develops and markets several cardiovascular drugs, positioning it as a competitor.
Abbvie
ABBV
Mkt Cap466.45B
AbbVie, with its acquisition of Allergan, has expanded its portfolio to include cardiovascular treatments, competing with Milestone.
Astrazeneca
AZN
Mkt Cap257.57B
AstraZeneca has a strong focus on cardiovascular and metabolic diseases, making it a direct competitor.
Gilead Sciences
GILD
Mkt Cap186.13B
Gilead Sciences, known for its work in antiviral drugs, also competes in the cardiovascular space.
Johnson & Johnson
JNJ
Mkt Cap650.65B
Johnson & Johnson, through its pharmaceutical division Janssen, offers cardiovascular drugs, competing with Milestone.
Sanofi
SNY
Mkt Cap101.79B
Sanofi has a diversified healthcare portfolio that includes cardiovascular drugs, making it a competitor.

About

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Show more...
CEO
ISIN
CA59935V1076

Listings

XNAS
US
MIST
BOATS
BOATS
MIST.BOATS

0 Comments

Share your thoughts

FAQ

What is Milestone Pharmaceuticals stock price today?▼
The current price of MIST.BOATS is $1.22 USD — it has decreased by -1.61% in the past 24 hours. Watch Milestone Pharmaceuticals stock price performance more closely on the chart.
What is Milestone Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Milestone Pharmaceuticals stocks are traded under the ticker MIST.BOATS.
What is Milestone Pharmaceuticals market cap?▼
Today Milestone Pharmaceuticals has the market capitalization of 151.89M
When is the next Milestone Pharmaceuticals earnings date?▼
Milestone Pharmaceuticals is going to release the next earnings report on November 17, 2026.
What were Milestone Pharmaceuticals earnings last quarter?▼
MIST.BOATS earnings for the last quarter are -0.21 USD per share, whereas the estimation was -0.2 USD resulting in a -7.69% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Milestone Pharmaceuticals revenue for the last year?▼
Milestone Pharmaceuticals revenue for the last year amounts to 1.55M USD.
What is Milestone Pharmaceuticals net income for the last year?▼
MIST.BOATS net income for the last year is -63.06M USD.
In which sector is Milestone Pharmaceuticals located?▼
Milestone Pharmaceuticals operates in the Other sector.
When did Milestone Pharmaceuticals complete a stock split?▼
Milestone Pharmaceuticals has not had any recent stock splits.